Abstract Malignant myoepithelioma (MM) of parapharyngeal space provide both a diagnostic and therapeutic challenge. Malignant myoepitheliomas are rare tumour of salivary glands. Most occur in the parotid gland, few other sites of origin are described. Malignant myoepithelioma of the parapharyngeal space are extremely rare with only a few cases has been reported. We present a case of malignant myoepithelioma in the parapharyngeal space and discuss its diagnostic and therapeutic aspects.
Introduction
Neoplasms arising in the parapharyngeal space constitute 0.5% of all head and neck tumours. The majority of these are benign (70%) and 45% are of salivary gland origin [1] . Myoepitheliomas are rare tumours that account for about 1% of all salivary gland tumours. Most are benign, but some have been malignant. The latter, even rarer, entity has been termed malignant myoepithelioma (MM) or myoepithelial carcinoma and represents about 10% of myoepitheliomas. In 1943, Sheldon fi rst used the term myoepithelioma and in 1975 Stromeyer et al [2] reported the fi rst case of MM. Most common site of MMs are in parotid gland, other sites such as the oral cavity, palate, retromolar area, cheek, lacrimal gland, breast, larynx, nasopharynx has been involved.
We present a case of Malignant Myoepithelioma in the parapharyngeal space and discuss its therapeutic aspects.
Case report
A 28-year-old women presented with a four month history of a painless mass in right tonsillar region with fullness in right retromandibular groove. She reported no dysphagia nor history suggestive of upper airway problem. On examination there was a smooth bulge involving (R) side of soft palate and (R) tonsil pushed medially. The swelling was fi rm, mobile and covered with intact mucosa.
Computed tomography (CT) showed a mixed density mass in the (R) parapharyngeal space with no obvious lymphnode enlargement (Fig. 1) . A fi ne needle aspiration cytology from swelling showed clusters of dark staining cells in the myxoid back ground and pathologist advised excision biopsy.
Patient underwent excision of the mass via combined transoral and transcervical approach. Tumour was well encapsulated and it was then enucleated from the parapharygneal space. The patient made an uneventful post operative recovery and post operative chemo-radiation was given.
The fi rst histopathological examination with low power showed numerous sheets and cords of neoplastic cells in a myxoid background with area of central necrosis (Fig. 2) . High power showed both spindle-shaped and epitheloid neoplastic cells with mitotic activity suggestive of malignant myoepithelioma (Fig. 3 ). 
Discussion
Salivary gland neoplasms composed of exclusively of myoepithelial cells (myoepitheliomas) are unusual and intriguing. A majority of the myoepitheliomas described in the literature has been benign and the malignant counterpart has been recognized recently. However, the precise criteria for inclusion of a tumour in this category still remain controversial. Some authors consider it a variation of the pleomorphic adenoma. Others defi ne it as a tumour composed solely of myoepithelial cells. Myoepitheliomas and MMs are considered as two separate clinical pathological entities. MMs are tumours of epithelial origin that may occur with pre-existing benign lesion like pleomorphic adenomas or benign myoepitheliomas but then also may arise de novo.
MM are usually a slow-growing painless mass that originates in the parotid gland, however, other sites such as the palate, nasopharynx, lacrimal sac, larynx, cheek and breast have also been reported. Usually affects patients over 50 years old, with no gender preference. Because this seldom associated with pain, their diagnosis can be delayed by months or even years.
When these involve the pharynx, MMs produce symptoms like dysphagia, respiratory problems. Retromandibular swelling or medial displacement of tonsil or lateral wall of pharynx has been found on physical examination.
Physical examination of lesion in the parapharyngeal space is limited by their location and so radiological imaging is critical in their evaluation (CT and MRI). CT allows the site and the extension of tumour. MRI is more precise in defi ning the tumours relationship with the adjacent structures and internal carotid A.
Histologically, two basic growth patterns were identifi ed in these neoplasms. These include a multinodular growth pattern and a diffuse sheet-like arrangement of tumour cells. A wide variety of morphologic tumour cell types was found in these MMs. More than one cell types are seen in majority of tumour. However in the majority of the neoplasms one cell type prevailed. The various cell types present in these tumours were categorized as follows: Epitheloid, Clear, Hyaline (plasmacytoid), Spindle and Mixed [3] . Immunohistochemically the tumour cells in malignant myoepitheliomas are immuno reactive to cytokeratin, smooth muscle actin, and S-100 protein, vimentin, and muscle-specifi c actin.
There are no discernible histologic features that correlate clearly with behaviour. Overall, most tumours that display marked histologic aggressiveness (cytologic atypia, high mitotic rate and necrosis) behaved adversely, but others with similar histologic features have been relatively indolent [3] . Conversely, occasional low-grade tumours with minimal mitotic activity have metastasized, and a few have been caused patients demis [4] . Di Palma and Guzza [5] 
